Strategies to promote implementation of core outcomes for medication adherence trials in rheumatology: A report from the OMERACT-Adherence Group

Aria Mohammadi Kordkheili; Charlotte Bekker; Alison M Hoens; Marieke Voshaar; Willemina Campbell; Loreto Carmona; Maarten de Wit; Lyn March; Sabrina Mai Nielsen; Beverley J Shea; Karine Toupin-April; Peter Tugwell; Kathleen Tymms; Ayano Kelly; Adherence Working Group

doi:10.1016/j.semarthrit.2024.152411

Strategies to promote implementation of core outcomes for medication adherence trials in rheumatology: A report from the OMERACT-Adherence Group

Aria Mohammadi Kordkheili, Charlotte Bekker, Alison M Hoens, Marieke Voshaar, Willemina Campbell, Loreto Carmona, Maarten de Wit, Lyn March, Sabrina Mai Nielsen, Beverley J Shea, Karine Toupin-April, Peter Tugwell, Kathleen Tymms, Ayano Kelly, Adherence Working Group

The Parker Institute

1 Citation (Scopus)

Abstract

OBJECTIVES: To identify barriers, facilitators, and strategies for future implementation of the OMERACT-Adherence Core Outcome Set (COS) in medication adherence trials for rheumatic conditions.

METHODS: Preliminary Delphi survey findings were discussed at OMERACT 2023, utilising the Consolidated Framework for Implementation Research 2 to identify implementation barriers, facilitators, and solutions.

RESULTS: Implementation strategies included simplifying the COS definitions, making it adaptabile for clinical practice and drug trials, adherence trial training workshops, and collaborating with key stakeholders such as payers and other COS developers.

CONCLUSION: Ongoing collaboration with individuals and organisations within and beyond rheumatology ensures broader applicability of OMERACT-Adherence COS.

Original language	English
Article number	152411
Journal	Seminars in Arthritis and Rheumatism
Volume	66
ISSN	0049-0172
DOIs	https://doi.org/10.1016/j.semarthrit.2024.152411
Publication status	Published - Jun 2024

Keywords

Humans
Medication Adherence
Rheumatology
Rheumatic Diseases/drug therapy
Antirheumatic Agents/therapeutic use
Delphi Technique
Clinical Trials as Topic
Outcome Assessment, Health Care
Medication adherence
OMERACT
Implementation

Access to Document

10.1016/j.semarthrit.2024.152411

Cite this

Kordkheili, A. M., Bekker, C., Hoens, A. M., Voshaar, M., Campbell, W., Carmona, L., de Wit, M., March, L., Nielsen, S. M., Shea, B. J., Toupin-April, K., Tugwell, P., Tymms, K., Kelly, A., & Adherence Working Group (2024). Strategies to promote implementation of core outcomes for medication adherence trials in rheumatology: A report from the OMERACT-Adherence Group. Seminars in Arthritis and Rheumatism, 66, Article 152411. https://doi.org/10.1016/j.semarthrit.2024.152411

Strategies to promote implementation of core outcomes for medication adherence trials in rheumatology: A report from the OMERACT-Adherence Group. / Kordkheili, Aria Mohammadi; Bekker, Charlotte; Hoens, Alison M et al.
In: Seminars in Arthritis and Rheumatism, Vol. 66, 152411, 06.2024.

Research output: Contribution to journal › Journal article › Research › peer-review

Kordkheili, AM, Bekker, C, Hoens, AM, Voshaar, M, Campbell, W, Carmona, L, de Wit, M, March, L, Nielsen, SM, Shea, BJ, Toupin-April, K, Tugwell, P, Tymms, K, Kelly, A & Adherence Working Group 2024, 'Strategies to promote implementation of core outcomes for medication adherence trials in rheumatology: A report from the OMERACT-Adherence Group', Seminars in Arthritis and Rheumatism, vol. 66, 152411. https://doi.org/10.1016/j.semarthrit.2024.152411

@article{020b96db37ee4e3aa8c197d42758a2ae,

title = "Strategies to promote implementation of core outcomes for medication adherence trials in rheumatology: A report from the OMERACT-Adherence Group",

abstract = "OBJECTIVES: To identify barriers, facilitators, and strategies for future implementation of the OMERACT-Adherence Core Outcome Set (COS) in medication adherence trials for rheumatic conditions.METHODS: Preliminary Delphi survey findings were discussed at OMERACT 2023, utilising the Consolidated Framework for Implementation Research 2 to identify implementation barriers, facilitators, and solutions.RESULTS: Implementation strategies included simplifying the COS definitions, making it adaptabile for clinical practice and drug trials, adherence trial training workshops, and collaborating with key stakeholders such as payers and other COS developers.CONCLUSION: Ongoing collaboration with individuals and organisations within and beyond rheumatology ensures broader applicability of OMERACT-Adherence COS.",

keywords = "Humans, Medication Adherence, Rheumatology, Rheumatic Diseases/drug therapy, Antirheumatic Agents/therapeutic use, Delphi Technique, Clinical Trials as Topic, Outcome Assessment, Health Care, Medication adherence, OMERACT, Implementation",

author = "Kordkheili, \{Aria Mohammadi\} and Charlotte Bekker and Hoens, \{Alison M\} and Marieke Voshaar and Willemina Campbell and Loreto Carmona and \{de Wit\}, Maarten and Lyn March and Nielsen, \{Sabrina Mai\} and Shea, \{Beverley J\} and Karine Toupin-April and Peter Tugwell and Kathleen Tymms and Ayano Kelly and \{Adherence Working Group\}",

note = "Copyright {\textcopyright} 2024. Published by Elsevier Inc.",

year = "2024",

month = jun,

doi = "10.1016/j.semarthrit.2024.152411",

language = "English",

volume = "66",

journal = "Seminars in Arthritis and Rheumatism",

issn = "0049-0172",

publisher = "W.B. Saunders",

}

TY - JOUR

T1 - Strategies to promote implementation of core outcomes for medication adherence trials in rheumatology

T2 - A report from the OMERACT-Adherence Group

AU - Kordkheili, Aria Mohammadi

AU - Bekker, Charlotte

AU - Hoens, Alison M

AU - Voshaar, Marieke

AU - Campbell, Willemina

AU - Carmona, Loreto

AU - de Wit, Maarten

AU - March, Lyn

AU - Nielsen, Sabrina Mai

AU - Shea, Beverley J

AU - Toupin-April, Karine

AU - Tugwell, Peter

AU - Tymms, Kathleen

AU - Kelly, Ayano

AU - Adherence Working Group

PY - 2024/6

Y1 - 2024/6

N2 - OBJECTIVES: To identify barriers, facilitators, and strategies for future implementation of the OMERACT-Adherence Core Outcome Set (COS) in medication adherence trials for rheumatic conditions.METHODS: Preliminary Delphi survey findings were discussed at OMERACT 2023, utilising the Consolidated Framework for Implementation Research 2 to identify implementation barriers, facilitators, and solutions.RESULTS: Implementation strategies included simplifying the COS definitions, making it adaptabile for clinical practice and drug trials, adherence trial training workshops, and collaborating with key stakeholders such as payers and other COS developers.CONCLUSION: Ongoing collaboration with individuals and organisations within and beyond rheumatology ensures broader applicability of OMERACT-Adherence COS.

AB - OBJECTIVES: To identify barriers, facilitators, and strategies for future implementation of the OMERACT-Adherence Core Outcome Set (COS) in medication adherence trials for rheumatic conditions.METHODS: Preliminary Delphi survey findings were discussed at OMERACT 2023, utilising the Consolidated Framework for Implementation Research 2 to identify implementation barriers, facilitators, and solutions.RESULTS: Implementation strategies included simplifying the COS definitions, making it adaptabile for clinical practice and drug trials, adherence trial training workshops, and collaborating with key stakeholders such as payers and other COS developers.CONCLUSION: Ongoing collaboration with individuals and organisations within and beyond rheumatology ensures broader applicability of OMERACT-Adherence COS.

KW - Humans

KW - Medication Adherence

KW - Rheumatology

KW - Rheumatic Diseases/drug therapy

KW - Antirheumatic Agents/therapeutic use

KW - Delphi Technique

KW - Clinical Trials as Topic

KW - Outcome Assessment, Health Care

KW - Medication adherence

KW - OMERACT

KW - Implementation

UR - https://www.scopus.com/pages/publications/85189089030

U2 - 10.1016/j.semarthrit.2024.152411

DO - 10.1016/j.semarthrit.2024.152411

M3 - Journal article

C2 - 38537323

SN - 0049-0172

VL - 66

JO - Seminars in Arthritis and Rheumatism

JF - Seminars in Arthritis and Rheumatism

M1 - 152411

ER -

Strategies to promote implementation of core outcomes for medication adherence trials in rheumatology: A report from the OMERACT-Adherence Group

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this